Circulating Tumor Cells (CTC) and Cell-Free DNA (cfDNA) Workshop 2016: Scientific Opportunities and Logistics for Cancer Clinical Trial Incorporation

Despite the identification of circulating tumor cells (CTCs) and cell-free DNA (cfDNA) as potential blood-based biomarkers capable of providing prognostic and predictive information in cancer, they have not been incorporated into routine clinical practice. This resistance is due in part to technolog...

Descripción completa

Detalles Bibliográficos
Autores principales: Lowes, Lori E., Bratman, Scott V., Dittamore, Ryan, Done, Susan, Kelley, Shana O., Mai, Sabine, Morin, Ryan D., Wyatt, Alexander W., Allan, Alison L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Conference Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5037782/
https://www.ncbi.nlm.nih.gov/pubmed/27618023
http://dx.doi.org/10.3390/ijms17091505

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5037782/
https://www.ncbi.nlm.nih.gov/pubmed/27618023
http://dx.doi.org/10.3390/ijms17091505

Ejemplares similares